Suppr超能文献

通冠胶囊对冠心病气虚血瘀证介入治疗后患者的影响

[Effect of Tongguan capsule on post-intervention patients of coronary heart disease with qi-deficiency and blood stasis syndrome].

作者信息

Li Jian, Zhang Min-Zhou, Chen Bo-Jun

机构信息

Second Affiliated Hospital of Guangzhou University of TCM, Guangzhou.

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Jan;28(1):32-5.

Abstract

OBJECTIVE

To observe the effect of Tongguan Capsule (TGC), a Chinese herbal preparation for supplementing qi and activating blood circulation, in patients after percutaneous coronary intervention (PCI) with qi-deficiency and blood stasis syndrome.

METHODS

One hundred patients after successful PCI operation were assigned to two groups, 50 in each group. Western routine therapy with anti-thrombosis and anti-coagulant agents were applied in all patients before, during and after operation, while to the patients in the treated group, TGC was given additionally. The therapeutic course for both groups was one month. The efficacy was evaluated by observing the effect on angina pectoris, main TCM syndromes and scores of qi-deficiency syndrome and blood stasis syndrome at 3 time points (the day before, 3 days and 30 days after operation).

RESULTS

The total effective rate in relieving angina pectoris was 96.0% (48/50) in the treated group and 92.0% (46/50) in the control group, showing insignificant difference between them (P > 0.05). The score of qi-deficiency in both groups raised 3 days after PCI as compared with that before PCI, but showed no statistical significance (P > 0.05); 30 days after PCI, it increased in the control group, as compared with that before PCI (P < 0.05). The score of blood stasis syndrome significantly lowered at the 3rd and the 30th day after PCI in both groups as compared with before PCI, showing statistical significance (P < 0.05); while in comparing the value at the 3rd day with that at the 30th day, the difference showed significance in the treated group but not in the control group (P < 0.05); and comparison between the two groups at the 30th day showed it was much lower in the treated group (P < 0.05).

CONCLUSION

TGC could significantly improve the clinical symptoms of qi-deficiency and blood stasis syndrome in patients after PCI.

摘要

目的

观察通冠胶囊(一种益气活血的中药制剂)对经皮冠状动脉介入治疗(PCI)术后气虚血瘀证患者的疗效。

方法

将100例PCI手术成功后的患者分为两组,每组50例。所有患者在手术前、手术中和手术后均采用抗血栓和抗凝剂的西医常规治疗,而治疗组患者在此基础上额外给予通冠胶囊。两组的疗程均为1个月。通过观察手术前、手术后3天和30天这3个时间点对心绞痛、主要中医证候以及气虚证和血瘀证评分的影响来评估疗效。

结果

治疗组缓解心绞痛的总有效率为96.0%(48/50),对照组为92.0%(46/50),两组间差异无统计学意义(P>0.05)。两组气虚评分在PCI术后3天较PCI术前均升高,但差异无统计学意义(P>0.05);PCI术后30天,对照组较PCI术前升高(P<0.05)。两组血瘀证评分在PCI术后第3天和第30天较PCI术前均显著降低,差异有统计学意义(P<0.05);而治疗组第3天与第30天比较差异有统计学意义,对照组差异无统计学意义(P<0.05);两组在第30天比较,治疗组明显低于对照组(P<0.05)。

结论

通冠胶囊可显著改善PCI术后患者气虚血瘀证的临床症状。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验